FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.8.2  |  FHIR Version n/a  User: [n/a]

773879000: Antineoplastic therapeutic role (role)

Status: current, Primitive. Date: 31-Jan 2019. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
3726859011 Antineoplastic therapeutic role en Synonym Active Case insensitive SNOMED CT core
3726860018 Antineoplastic therapeutic role (role) en Fully specified name Active Case insensitive SNOMED CT core

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Antineoplastic therapeutic role Is a Therapeutic role true Inferred relationship Some
Inbound Relationships Type Active Source Characteristic Refinability Group
Bendamustine hydrochloride 25 mg powder for solution for infusion vial Plays role True Antineoplastic therapeutic role Inferred relationship Some
Aminolevulinic acid hydrochloride (as 5-aminolevulinic acid) 30 mg/mL oral solution Plays role True Antineoplastic therapeutic role Inferred relationship Some
5-aminolevulinic acid-containing product in oral dose form Plays role True Antineoplastic therapeutic role Inferred relationship Some
5-aminolevulinic acid only product in oral dose form Plays role True Antineoplastic therapeutic role Inferred relationship Some
Trastuzumab 60 mg powder for solution for injection vial Plays role True Antineoplastic therapeutic role Inferred relationship Some
Hydroxycarbamide 100 mg oral tablet Plays role True Antineoplastic therapeutic role Inferred relationship Some
Triptorelin (as triptorelin pamoate) 11.25 mg powder for suspension for injection vial Plays role True Antineoplastic therapeutic role Inferred relationship Some
Carfilzomib 60 mg powder for solution for infusion vial Plays role True Antineoplastic therapeutic role Inferred relationship Some
Carfilzomib 10 mg powder for solution for infusion vial Plays role True Antineoplastic therapeutic role Inferred relationship Some
Carfilzomib 30 mg powder for solution for infusion vial Plays role True Antineoplastic therapeutic role Inferred relationship Some
Leuprorelin acetate 60 mg/mL suspension for injection Plays role True Antineoplastic therapeutic role Inferred relationship Some
Ruxolitinib (as ruxolitinib phosphate) 25 mg oral tablet Plays role True Antineoplastic therapeutic role Inferred relationship Some
Vinorelbine (as vinorelbine tartrate) 10 mg/mL solution for infusion and/or injection Plays role True Antineoplastic therapeutic role Inferred relationship Some
Arsenic trioxide 1 mg/mL solution for infusion and/or injection Plays role True Antineoplastic therapeutic role Inferred relationship Some
Arsenic trioxide 2 mg/mL solution for infusion and/or injection Plays role True Antineoplastic therapeutic role Inferred relationship Some
Brentuximab vedotin 50 mg powder for solution for infusion and/or injection vial Plays role True Antineoplastic therapeutic role Inferred relationship Some
Cladribine 1 mg/mL solution for infusion and/or injection Plays role True Antineoplastic therapeutic role Inferred relationship Some
Fluorouracil (as fluorouracil sodium) 50 mg/mL solution for infusion and/or injection Plays role True Antineoplastic therapeutic role Inferred relationship Some
Ipilimumab 5 mg/mL solution for infusion and/or injection Plays role True Antineoplastic therapeutic role Inferred relationship Some
Irinotecan hydrochloride trihydrate 20 mg/mL solution for infusion and/or injection Plays role True Antineoplastic therapeutic role Inferred relationship Some
Epirubicin hydrochloride 2 mg/mL solution for infusion and/or injection Plays role True Antineoplastic therapeutic role Inferred relationship Some
Trastuzumab emtansine 100 mg powder for solution for infusion and/or injection vial Plays role True Antineoplastic therapeutic role Inferred relationship Some
Trastuzumab emtansine 160 mg powder for solution for infusion and/or injection vial Plays role True Antineoplastic therapeutic role Inferred relationship Some
Rituximab 10 mg/mL solution for infusion and/or injection Plays role True Antineoplastic therapeutic role Inferred relationship Some
Doxorubicin hydrochloride 2 mg/mL solution for infusion and/or injection Plays role True Antineoplastic therapeutic role Inferred relationship Some
Alemtuzumab only product in parenteral dose form Plays role True Antineoplastic therapeutic role Inferred relationship Some
Alemtuzumab-containing product in parenteral dose form Plays role True Antineoplastic therapeutic role Inferred relationship Some
Clofarabine only product in parenteral dose form Plays role True Antineoplastic therapeutic role Inferred relationship Some
Clofarabine-containing product in parenteral dose form Plays role True Antineoplastic therapeutic role Inferred relationship Some
Mitoxantrone only product in parenteral dose form Plays role True Antineoplastic therapeutic role Inferred relationship Some
Mitoxantrone-containing product in parenteral dose form Plays role True Antineoplastic therapeutic role Inferred relationship Some
Mitoxantrone (as mitoxantrone hydrochloride) 2 mg/mL solution for infusion Plays role True Antineoplastic therapeutic role Inferred relationship Some
Alemtuzumab 10 mg/mL solution for infusion Plays role True Antineoplastic therapeutic role Inferred relationship Some
Clofarabine 1 mg/mL solution for infusion Plays role True Antineoplastic therapeutic role Inferred relationship Some
Dacarbazine (as dacarbazine citrate) 1 g powder for solution for infusion vial Plays role True Antineoplastic therapeutic role Inferred relationship Some
Dacarbazine (as dacarbazine citrate) 500 mg powder for solution for infusion vial Plays role True Antineoplastic therapeutic role Inferred relationship Some
Dacarbazine (as dacarbazine citrate) 200 mg powder for solution for infusion and/or injection vial Plays role True Antineoplastic therapeutic role Inferred relationship Some
Decitabine 50 mg powder for solution for infusion vial Plays role True Antineoplastic therapeutic role Inferred relationship Some
Obinutuzumab 25 mg/mL solution for infusion Plays role True Antineoplastic therapeutic role Inferred relationship Some
Gemcitabine (as gemcitabine hydrochloride) 40 mg/mL solution for infusion Plays role True Antineoplastic therapeutic role Inferred relationship Some
Cetuximab 5 mg/mL solution for injection Plays role True Antineoplastic therapeutic role Inferred relationship Some
Fludarabine phosphate 25 mg/mL solution for infusion Plays role True Antineoplastic therapeutic role Inferred relationship Some
Gemcitabine (as gemcitabine hydrochloride) 38 mg/mL solution for infusion Plays role True Antineoplastic therapeutic role Inferred relationship Some
Gemcitabine (as gemcitabine hydrochloride) 100 mg/mL solution for infusion Plays role True Antineoplastic therapeutic role Inferred relationship Some
Decitabine 50 mg powder for solution for infusion and/or injection vial Plays role True Antineoplastic therapeutic role Inferred relationship Some
Paclitaxel (as albumin bound paclitaxel) 100 mg powder for dispersion for infusion vial Plays role True Antineoplastic therapeutic role Inferred relationship Some
Paclitaxel (as albumin bound paclitaxel) 250 mg powder for dispersion for infusion vial Plays role True Antineoplastic therapeutic role Inferred relationship Some
Daratumumab 120 mg/mL solution for injection Plays role True Antineoplastic therapeutic role Inferred relationship Some
Azacitidine 100 mg powder for suspension for injection vial Plays role True Antineoplastic therapeutic role Inferred relationship Some
Carmustine 100 mg powder for solution for infusion and/or injection vial Plays role True Antineoplastic therapeutic role Inferred relationship Some
Carmustine 100 mg powder for solution for infusion vial Plays role True Antineoplastic therapeutic role Inferred relationship Some
Fluorouracil (as fluorouracil sodium) 25 mg/mL solution for infusion and/or injection Plays role True Antineoplastic therapeutic role Inferred relationship Some
Interferon beta-1a 44 microgram/mL solution for injection Plays role True Antineoplastic therapeutic role Inferred relationship Some
Interferon beta-1a 88 microgram/mL solution for injection Plays role True Antineoplastic therapeutic role Inferred relationship Some
Ofatumumab 50 mg/mL solution for injection Plays role True Antineoplastic therapeutic role Inferred relationship Some
Inotuzumab ozogamicin 1 mg powder for solution for infusion vial Plays role True Antineoplastic therapeutic role Inferred relationship Some
Ifosfamide 1 g powder for solution for infusion and/or injection vial Plays role True Antineoplastic therapeutic role Inferred relationship Some
Ifosfamide 2 g powder for solution for infusion and/or injection vial Plays role True Antineoplastic therapeutic role Inferred relationship Some
Methotrexate (as methotrexate sodium) 50 mg/mL solution for injection Plays role True Antineoplastic therapeutic role Inferred relationship Some
Gemtuzumab ozogamicin 5 mg powder for solution for infusion vial Plays role True Antineoplastic therapeutic role Inferred relationship Some
Gemtuzumab ozogamicin 5 mg powder for solution for infusion and/or injection vial Plays role True Antineoplastic therapeutic role Inferred relationship Some
Melphalan (as melphalan hydrochloride) 50 mg powder for solution for infusion and/or injection vial Plays role True Antineoplastic therapeutic role Inferred relationship Some
Melphalan (as melphalan hydrochloride) 50 mg powder for solution for infusion vial Plays role True Antineoplastic therapeutic role Inferred relationship Some
Leuprorelin acetate 3.75 mg powder for suspension for injection syringe Plays role True Antineoplastic therapeutic role Inferred relationship Some
Leuprorelin acetate 7.5 mg powder for suspension for injection syringe Plays role True Antineoplastic therapeutic role Inferred relationship Some
Leuprorelin acetate 45 mg powder for solution for injection syringe Plays role True Antineoplastic therapeutic role Inferred relationship Some
Leuprorelin acetate 22.5 mg powder for prolonged-release suspension for injection vial Plays role True Antineoplastic therapeutic role Inferred relationship Some
Leuprorelin acetate 11.25 mg powder for prolonged-release suspension for injection syringe Plays role True Antineoplastic therapeutic role Inferred relationship Some
Leuprorelin acetate 30 mg powder for prolonged-release suspension for injection syringe Plays role True Antineoplastic therapeutic role Inferred relationship Some
Cladribine 2 mg/mL solution for injection Plays role True Antineoplastic therapeutic role Inferred relationship Some
Topotecan (as topotecan hydrochloride) 1 mg powder for solution for infusion vial Plays role True Antineoplastic therapeutic role Inferred relationship Some
Topotecan (as topotecan hydrochloride) 1 mg powder for solution for infusion and/or injection vial Plays role True Antineoplastic therapeutic role Inferred relationship Some
Topotecan (as topotecan hydrochloride) 4 mg powder for solution for infusion and/or injection vial Plays role True Antineoplastic therapeutic role Inferred relationship Some
Topotecan (as topotecan hydrochloride) 4 mg powder for solution for infusion vial Plays role True Antineoplastic therapeutic role Inferred relationship Some
Thiotepa 15 mg powder for solution for infusion and/or injection vial Plays role True Antineoplastic therapeutic role Inferred relationship Some
Thiotepa 15 mg powder for solution for infusion vial Plays role True Antineoplastic therapeutic role Inferred relationship Some
Thiotepa 100 mg powder for solution for infusion vial Plays role True Antineoplastic therapeutic role Inferred relationship Some
Thiotepa 400 mg powder for solution for infusion bag Plays role True Antineoplastic therapeutic role Inferred relationship Some
Tasonermin 1 mg powder for solution for infusion vial Plays role True Antineoplastic therapeutic role Inferred relationship Some
Tasonermin-containing product in parenteral dose form Plays role True Antineoplastic therapeutic role Inferred relationship Some
Tasonermin only product in parenteral dose form Plays role True Antineoplastic therapeutic role Inferred relationship Some
Triptorelin (as triptorelin pamoate) 22.5 mg powder for prolonged-release suspension for injection vial Plays role True Antineoplastic therapeutic role Inferred relationship Some
Trabectedin 1 mg powder for solution for infusion vial Plays role True Antineoplastic therapeutic role Inferred relationship Some
Trabectedin 250 microgram powder for solution for injection vial Plays role True Antineoplastic therapeutic role Inferred relationship Some
Trastuzumab 420 mg powder for solution for infusion vial Plays role True Antineoplastic therapeutic role Inferred relationship Some
Trastuzumab 60 mg powder for solution for infusion vial Plays role True Antineoplastic therapeutic role Inferred relationship Some
Trastuzumab deruxtecan 100 mg powder for solution for infusion vial Plays role True Antineoplastic therapeutic role Inferred relationship Some
Trastuzumab 60 mg powder for solution for infusion and/or injection vial Plays role True Antineoplastic therapeutic role Inferred relationship Some
Pemetrexed (as pemetrexed disodium) 100 mg powder for solution for infusion vial Plays role True Antineoplastic therapeutic role Inferred relationship Some
Pemetrexed (as pemetrexed disodium) 500 mg powder for solution for infusion vial Plays role True Antineoplastic therapeutic role Inferred relationship Some
Hydroxycarbamide 100 mg/mL oral solution Plays role True Antineoplastic therapeutic role Inferred relationship Some
Larotrectinib (as larotrectinib sulfate) 20 mg/mL oral solution Plays role True Antineoplastic therapeutic role Inferred relationship Some

Start Previous Page 16 of 16

Reference Sets

Qualifier value foundation reference set

Back to Start